Filing Details

Accession Number:
0000899243-21-048432
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-15 20:09:26
Reporting Period:
2021-12-15
Accepted Time:
2021-12-15 20:09:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662244 Cyteir Therapeutics Inc. CYT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331852 S Joseph Zakrzewski 128 Spring St, Building A, Suite 510
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-15 2,000 $10.47 79,267 No 4 P Direct
Common Stock Acquisiton 2021-12-15 1,700 $11.12 80,967 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 58,671 Indirect See Footnote
Common Stock 149,051 Indirect See Footnote
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $9.95 to $10.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. 84,523 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
  3. The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $10.95 to $11.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  4. Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
  5. Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.